Role of Deguelin in Chemoresistance

Sankar Jagadeeshan, M. Manu Prasad, Shivakumari Asha Nair

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations

Abstract

Natural agents are emerging as candidates with strong potential for targeted therapy against cancer as “nutraceuticals.” Deguelin, a rotenoid isolated from Mundulea sericea (Leguminosae) or Derris trifoliata, has been identified as a potent chemopreventive nutraceutical. Compendium of literature exhibiting its significant antitumorigenesis and antiproliferative activity in various types of cancer both in vitro and in vivo has recommended deguelin as a novel nutraceutical targeting tumorigenesis, apoptosis, cell-cycle arrest, and anti-angiogenesis for cancer chemoprevention and chemotherapy. In this chapter, we provide an overall insight on the role of deguelin as a chemosensitizer and its mechanism of action against cancer.

Original languageEnglish
Title of host publicationRole of Nutraceuticals in Cancer Chemosensitization
Subtitle of host publicationVolume 2
PublisherElsevier
Pages287-296
Number of pages10
Volume2
ISBN (Electronic)9780128123737
ISBN (Print)9780128123744
DOIs
StatePublished - 1 Jan 2017
Externally publishedYes

Keywords

  • Cancer
  • Chemoprevention
  • Deguelin
  • Mechanism
  • Nutraceuticals

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Role of Deguelin in Chemoresistance'. Together they form a unique fingerprint.

Cite this